Search



Author: dse7xy@virginia.edu

UVA Partners with Boys and Girls Club of Central Virginia to Offer Hands-On Learning in Medicine

9/30/2025

The UVA Departments of Pathology, Surgery, and Anesthesiology collaborated with the Boys and Girls Club of Central Virginia to host an annual community event that welcomed local middle school students…

UVA Health Day Camp

9/30/2025

Several departments at UVA, including the Department of Pathology, collaborated with the Housestaff Community Development Initiative (HCDI) and Charlottesville’s City of Promise to host UVA Health Day Camp introducing local…

Anne Mills, M.D. Wins 2025 MD Early Achievement Award

9/18/2025

The UVA Department of Pathology Residency Program Director, Anne Mills, M.D., is the recipient of the 2025 MD Early Achievement Award. See here for more info. 

Natalie Hillerson wins Mulholland Award

9/18/2025

2025 PGY4 and Chief Resident Natalie Hillerson has been awarded the Mulholland Award for Teaching Excellence in Basic Sciences. Each year, the Mulholland Society and Graduate Medical Education office call…

PGY4 Natalie Hillerson is a Kinney Scholar

9/18/2025

PGY4 and Chief Resident Natalie Hillerson was selected to attend the Association for Academic Pathology (AAPath) 2025 Annual Meeting in Denver, CO as a Kinney Scholar in July 2025. She…

Michelle Barbeau, PhD, “Systems-level characterization of the transcriptional and signaling basis of epithelial-mesenchymal transition heterogeneity in pancreatic ductal adenocarcinoma”, 2025

8/28/2025

Abstract: Epithelial-mesenchymal transition (EMT) is a developmental program aberrantly activated in pancreatic ductal adenocarcinoma (PDAC), promoting chemoresistance and metastasis. Antagonizing EMT may be an effective adjuvant therapy approach to promote…

Lydia Kitelinger, PhD, “Immunological effects of focused ultrasound as a therapy for melanoma and breast cancer”, 2025

8/28/2025

Abstract: Focused ultrasound (FUS) is a clinically relevant and attractive therapeutic, due to its non-invasive and non-ionizing nature. By employing FUS, solid malignancies can be targeted and destroyed via mechanical…

Nikit Yadav, PhD, “Synergistic activity of combining repurposed simvastatin with irinotecan chemotherapy against glioblastoma and its underlying mechanisms”, 2025

8/28/2025

Abstract: Background and Rationale: Glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a dismal prognosis (approximately 15 months) and inevitable recurrence due to resistance towards standard-of-care…

Ryan Makin, PhD, “Evaluating the role of inflammasome activation in models of pathological ocular angiogenesis”, 2025

8/28/2025

Abstract: Pathological angiogenesis in the eye remains at the center of a myriad blinding diseases, including neovascular age-related macular degeneration (nvAMD). Elucidating the mechanisms by which these invasive neovessels proliferate…

Dionne Argyle, PhD, “Sex Differences in IgG1-Mediated Inhibition of Choroidal Neovascularization”, 2025

8/28/2025

Abstract: Sex differences significantly impact diseases involving angiogenesis, such as age- related macular degeneration (AMD), which is more prevalent in females. The basis for this sexual dimorphism is unknown. Using…